Therapeutic protein drugs have become an important class of medicines serving patients in dire need for novel therapies. Lately approved recombinant protein therapeutics have been propelled to treat an array of clinical indications, such as inflammation, cancers, genetic disorders and exposure to infectious agents. The development in protein plasma protein have leveraged manufacturers and drug developers to exploit and fine-tune protein’s functional characteristics and improving/maintaining ... Read more
